Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Challenges in the identification of methicillin-resistant Staphylococcus argenteus by routine diagnostics.

Tunsjø HS, Kalyanasundaram S, Charnock C, Leegaard TM, Moen AEF.

APMIS. 2018 Jun;126(6):533-537. doi: 10.1111/apm.12843.

PMID:
29924450
2.

Planning for the Rheumatologist Workforce: Factors Associated With Work Hours and Volumes.

Barber CEH, Nasr M, Barnabe C, Badley EM, Lacaille D, Pope J, Cividino A, Yacyshyn E, Baillie C, Mosher D, Thomson JG, Charnock C, Thorne JC, Zummer M, Brophy J, Ruban TN, Ahluwalia V, McDougall R, Marshall DA.

J Clin Rheumatol. 2018 May 25. doi: 10.1097/RHU.0000000000000803. [Epub ahead of print]

PMID:
29846270
3.

Use of a Commercially Available Microarray to Characterize Antibiotic-Resistant Clinical Isolates of Klebsiella pneumoniae.

Charnock C, Samuelsen Ø, Nordlie AL, Hjeltnes B.

Curr Microbiol. 2018 Feb;75(2):163-172. doi: 10.1007/s00284-017-1361-4. Epub 2017 Sep 22.

PMID:
28940091
4.

Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada.

Barber CE, Jewett L, Badley EM, Lacaille D, Cividino A, Ahluwalia V, Averns H, Baillie C, Ellsworth J, Pope J, Levy D, Charnock C, McGowan C, Thorne JC, Barnabe C, Zummer M, Lundon K, McDougall RS, Thomson JG, Yacyshyn EA, Mosher D, Brophy J, Ruban TN, Marshall DA.

J Rheumatol. 2017 Feb;44(2):248-257. doi: 10.3899/jrheum.160621. Epub 2016 Dec 1.

PMID:
27909087
5.

Proteobacteria, extremophiles and unassigned species dominate in a tape-like showerhead biofilm.

Charnock C, Nordlie AL.

Braz J Microbiol. 2016 Apr-Jun;47(2):345-51. doi: 10.1016/j.bjm.2016.01.018. Epub 2016 Mar 2.

6.

Treatment stage associated changes in cellular and molecular microbial markers during the production of drinking water at the Vansjø water works.

Charnock C, Otterholt E, Nordlie AL.

Water Res. 2015 Sep 15;81:240-9. doi: 10.1016/j.watres.2015.06.002. Epub 2015 Jun 6.

PMID:
26074187
7.

Toxin production and antibiotic resistances in Escherichia coli isolated from bathing areas along the coastline of the Oslo fjord.

Charnock C, Nordlie AL, Hjeltnes B.

Curr Microbiol. 2014 Sep;69(3):317-28. doi: 10.1007/s00284-014-0587-7. Epub 2014 May 7.

PMID:
24801333
8.

Chiral N-benzyl-N-methyl-1-(naphthalen-1-yl)ethanamines and their in vitro antifungal activity against Cryptococcus neoformans, Trichophyton mentagrophytes and Trichophyton rubrum.

Thvedt TH, Kaasa K, Sundby E, Charnock C, Hoff BH.

Eur J Med Chem. 2013 Oct;68:482-96. doi: 10.1016/j.ejmech.2013.07.043. Epub 2013 Aug 15.

PMID:
24051242
9.

Activity of 6-aryl-pyrrolo[2,3-d]pyrimidine-4-amines to Tetrahymena.

Kaspersen SJ, Sundby E, Charnock C, Hoff BH.

Bioorg Chem. 2012 Oct;44:35-41. doi: 10.1016/j.bioorg.2012.06.003. Epub 2012 Jul 6.

PMID:
22832269
10.

Evaluation of preservative efficacy in pharmaceutical products: the use of psychrotolerant, low-nutrient preferring microbes in challenge tests.

Charnock C, Otterholt E.

J Clin Pharm Ther. 2012 Oct;37(5):558-64. doi: 10.1111/j.1365-2710.2012.01354.x. Epub 2012 May 17.

PMID:
22591271
11.

Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles.

Khoje AD, Charnock C, Wan B, Franzblau S, Gundersen LL.

Bioorg Med Chem. 2011 Jun 1;19(11):3483-91. doi: 10.1016/j.bmc.2011.04.023. Epub 2011 Apr 20.

PMID:
21546254
12.

Identification and phylogeny of the small eukaryote population of raw and drinking waters.

Otterholt E, Charnock C.

Water Res. 2011 Apr;45(8):2527-38. doi: 10.1016/j.watres.2011.02.008. Epub 2011 Feb 17.

PMID:
21382633
13.

Antimicrobial and antineoplastic activities of agelasine analogs modified in the purine 2-position.

Roggen H, Charnock C, Burman R, Felth J, Larsson R, Bohlin L, Gundersen LL.

Arch Pharm (Weinheim). 2011 Jan;344(1):50-5. doi: 10.1002/ardp.201000148. Epub 2010 Nov 25.

PMID:
21213351
14.

Microbial quality and nutritional aspects of Norwegian brand waters.

Otterholt E, Charnock C.

Int J Food Microbiol. 2011 Jan 5;144(3):455-63. doi: 10.1016/j.ijfoodmicro.2010.10.034. Epub 2010 Nov 4.

PMID:
21095035
15.

Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring.

Khoje AD, Kulendrn A, Charnock C, Wan B, Franzblau S, Gundersen LL.

Bioorg Med Chem. 2010 Oct 15;18(20):7274-82. doi: 10.1016/j.bmc.2010.08.016. Epub 2010 Aug 13.

PMID:
20833056
16.

Synthesis and antimycobacterial activity of 5-formylaminopyrimidines; analogs of antibacterial purines.

Braendvang M, Charnock C, Gundersen LL.

Bioorg Med Chem Lett. 2009 Jun 15;19(12):3297-9. doi: 10.1016/j.bmcl.2009.04.082. Epub 2009 Apr 23.

PMID:
19427200
17.

Combining esters of para-hydroxy benzoic acid (parabens) to achieve increased antimicrobial activity.

Charnock C, Finsrud T.

J Clin Pharm Ther. 2007 Dec;32(6):567-72.

PMID:
18021333
18.

Synthesis, antimicrobial and antineoplastic activities for agelasine and agelasimine analogs with a beta-cyclocitral derived substituent.

Proszenyák A, Charnock C, Hedner E, Larsson R, Bohlin L, Gundersen LL.

Arch Pharm (Weinheim). 2007 Dec;340(12):625-34.

PMID:
17994607
19.

Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs.

Vik A, Hedner E, Charnock C, Tangen LW, Samuelsen Ø, Larsson R, Bohlin L, Gundersen LL.

Bioorg Med Chem. 2007 Jun 15;15(12):4016-37. Epub 2007 Apr 2.

PMID:
17442577
20.

Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis.

Gundersen LL, Charnock C, Negussie AH, Rise F, Teklu S.

Eur J Pharm Sci. 2007 Jan;30(1):26-35. Epub 2006 Oct 1.

PMID:
17079120
21.

Biocidal activity of a bioactive glass-protected, preservative-free tattooing solution.

Charnock C.

Am J Infect Control. 2006 Jun;34(5):290-5.

PMID:
16765208
22.

Are multidose over-the-counter artificial tears adequately preserved?

Charnock C.

Cornea. 2006 May;25(4):432-7. Erratum in: Cornea. 2006 Jul;25(6):760.

PMID:
16670481
23.

(+)-agelasine D: improved synthesis and evaluation of antibacterial and cytotoxic activities.

Vik A, Hedner E, Charnock C, Samuelsen O, Larsson R, Gundersen LL, Bohlin L.

J Nat Prod. 2006 Mar;69(3):381-6.

PMID:
16562840
24.

Dirty magazines.

Charnock C.

Br J Gen Pract. 2005 Jul;55(516):560. No abstract available.

25.

Controlling the proliferation of Zygosaccharomyces bailii in ephedrine anti-phlegm cough mixture.

Charnock C, Finsrud T, Foss C.

J Clin Pharm Ther. 2005 Aug;30(4):329-35.

PMID:
15985046
26.
27.

The microbial content of non-sterile pharmaceuticals distributed in Norway.

Charnock C.

J Hosp Infect. 2004 Jul;57(3):233-40.

PMID:
15236853
28.

Evaluation of the antibacterial efficacy of diesters of azelaic acid.

Charnock C, Brudeli B, Klaveness J.

Eur J Pharm Sci. 2004 Apr;21(5):589-96.

PMID:
15066659
29.

[Tattooing dyes and pigments contaminated with bacteria].

Charnock C.

Tidsskr Nor Laegeforen. 2004 Apr 1;124(7):933-5. Norwegian.

30.
33.
34.

Multilocus enzyme electrophoresis of major O-antigen reference strains of Pseudomonas aeruginosa.

Charnock C, Bergan T.

Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):810-6.

PMID:
1281769

Supplemental Content

Loading ...
Support Center